The association of IL28B genotype with peginterferon-α/ribavirin ( PR) treatment outcome and liver interferon-stimulated gene (ISG) expression is determined by HCV genotype

被引:0
|
作者
Holmes, Jacinta A. [1 ,2 ]
Congiu, Mario [2 ]
Bonanazinga, Sara [3 ]
Sandhu, Manjeet K. [1 ]
Kia, Yin H. [1 ]
Bell, Sally [1 ]
Visvanathan, Kumar [4 ]
Sievert, William [4 ]
Bowden, Scott [3 ]
Desmond, Paul V. [1 ,2 ]
Thompson, Alexander J. [1 ,2 ]
机构
[1] St Vincents Hosp, Fitzroy, Vic 3065, Australia
[2] Univ Melbourne, Carlton, Vic 3053, Australia
[3] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia
[4] Monash Univ, Monash Med Ctr, Clayton, Vic, Australia
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1822
引用
收藏
页码:1042A / 1043A
页数:2
相关论文
共 50 条
  • [41] IL28B GENETIC VARIATION AND TREATMENT RESPONSE IN PATIENTS WITH HCV GENOTYPE 3 INFECTION
    Dalgard, Olav
    Moghaddam, Amir
    Verbaan, Hans
    Ring-Larsen, Helmer
    Bjoro, Kristian
    Melum, Espen
    HEPATOLOGY, 2010, 52 (04) : 751A - 751A
  • [42] Inverse Association of IL28B Genotype and Liver mRNA Expression of Genes Promoting or Suppressing Antiviral State
    Abe, Hiromi
    Hayes, C. Nelson
    Ochi, Hidenori
    Tsuge, Masataka
    Miki, Daiki
    Hiraga, Nobuhiko
    Imamura, Michio
    Takahashi, Shoichi
    Kubo, Michiaki
    Nakamura, Yusuke
    Kamatani, Naoyuki
    Chayama, Kazuaki
    JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (09) : 1597 - 1607
  • [43] IL28B genotype is not useful for predicting pegylated-interferon-α treatment outcome in Asian chronic hepatitis B cohorts
    Holmes, Jacinta A.
    Tin Nguyen
    Ratnam, Dilip
    Heerasing, Neel M.
    Tehan, Jane V.
    Chen, Robert
    Dev, Anouk
    Bell, Sally
    Pianko, Stephen
    Bonanzinga, Sara
    Visvanathan, Kumar
    Rusli, Ferry
    Locarnini, Stephen
    Sievert, William
    Bowden, D. Scott
    Desmond, Paul
    Thompson, Alex
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 166 - 167
  • [44] IL28B genotype is not associated with differential gene expression in a large cohort of patients without known HCV infection
    Jilg, Nikolaus
    Hatoum, Ida J.
    Greenawalt, Danielle M.
    Lin, Wenyu
    Kaplan, Lee M.
    Chung, Raymond T.
    HEPATOLOGY, 2013, 58 : 976A - 976A
  • [45] Core mutations, IL28B polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1 infection
    Alestig, Erik
    Arnholm, Birgitta
    Eilard, Anders
    Lagging, Martin
    Nilsson, Staffan
    Norkrans, Gunnar
    Wahlberg, Thomas
    Wejstal, Rune
    Westin, Johan
    Lindh, Magnus
    BMC INFECTIOUS DISEASES, 2011, 11
  • [46] Core mutations, IL28B polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1 infection
    Erik Alestig
    Birgitta Arnholm
    Anders Eilard
    Martin Lagging
    Staffan Nilsson
    Gunnar Norkrans
    Thomas Wahlberg
    Rune Wejstål
    Johan Westin
    Magnus Lindh
    BMC Infectious Diseases, 11
  • [47] Interferon-Induced Gene Expression Is a Stronger Predictor of Treatment Response Than IL28B Genotype in Patients With Hepatitis C
    Dill, Michael T.
    Duong, Francois H. T.
    Vogt, Julia E.
    Bibert, Stephanie
    Bochud, Pierre-Yves
    Terracciano, Luigi
    Papassotiropoulos, Andreas
    Roth, Volker
    Heim, Markus H.
    GASTROENTEROLOGY, 2011, 140 (03) : 1021 - U471
  • [48] Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients with hepatitis C virus genotype 4
    Shiha, Gamal
    Samir, Waleed
    Seif, Seham
    El-Etreby, Shahira A.
    Abdel-Khalek, Ehab
    HEPATOLOGY, 2012, 56 : 1023A - 1023A
  • [49] Pre-treatment IP-10 levels and IL28B genotype as predictive markers for SVR in treatment-naive patients with genotype 1 HCV infection treated with telaprevir/peginterferon/ribavirin in the OPTIMIZE study
    Vijgen, Leen
    Dierynck, Inge
    Janssen, Katrien
    Talloen, Willem
    Gys, Luc
    Vanhoof, Greet
    Luo, Donghan
    De Meyer, Sandra
    Witek, James
    Aerssens, Jeroen
    HEPATOLOGY, 2013, 58 : 1096A - 1097A
  • [50] HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy
    Hayes, C. Nelson
    Kobayashi, Mariko
    Akuta, Norio
    Suzuki, Fumitaka
    Kumada, Hiromitsu
    Abe, Hiromi
    Miki, Daiki
    Imamura, Michio
    Ochi, Hidenori
    Kamatani, Naoyuki
    Nakamura, Yusuke
    Chayama, Kazuaki
    GUT, 2011, 60 (02) : 261 - 267